Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-11-036546)

Filing Details

Accession Number:: 0001144204-11-036546
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-20 18:13:40
Reporting Period:: 2011-06-17

Filing Date:: 2011-06-20
Accepted Time:: 2011-06-20 17:13:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326190	Pharmathene Inc	PIP	Pharmaceutical Preparations (2834)	202726770

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479091	W. Jeffrey Runge	C/O Pharmathene, Inc., One Park Place Suite 450 Annapolis MD 21401		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value Per Share	Acquisiton	2011-06-17	17,850	$2.69	17,850	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.679 to $2.730 per share. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on June 17, 2011.